Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylateElias Jabbour, Jörge E. Cortes, Hagop M. Kantarjian et al.|Leukemia|2006Cited by 387
Classifying Colorectal Cancer by Tumor Location Rather than Sidedness Highlights a Continuum in Mutation Profiles and Consensus Molecular SubtypesJonathan M. Loree, Scott Kopetz, Allan Andresson Lima Pereira et al.|Clinical Cancer Research|2017Cited by 318
Frequency and Spectrum of BRAF Mutations in a Retrospective, Single-Institution Study of 1112 Cases of MelanomaWesley O. Greaves, Rajyalakshmi Luthra, Shalini Verma et al.|Journal of Molecular Diagnostics|2012Cited by 217
TP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseasesChi Young Ok, Sa A. Wang, Keyur P. Patel et al.|Journal of Hematology & Oncology|2015Cited by 142
Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseasesChi Young Ok, Sa A. Wang, Keyur P. Patel et al.|Leukemia Research|2014Cited by 128